Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-03-05
2010-06-29
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S411000, C540S456000
Reexamination Certificate
active
07745457
ABSTRACT:
A compound of the structureis described. This compound and its use for preparing medicines useful in the treatment of neurodegenerative disorders is described.
REFERENCES:
patent: 7247650 (2007-07-01), Summers
patent: 2005/0197356 (2005-09-01), Graziani et al.
patent: 2005/0197379 (2005-09-01), Summers et al.
patent: 2005/0272133 (2005-12-01), He et al.
patent: 2006/0135549 (2006-06-01), Graziani et al.
patent: 2006/0135550 (2006-06-01), Graziani et al.
patent: 2006/0141583 (2006-06-01), Haltli
patent: WO 94/18207 (1994-08-01), None
patent: WO 95/06649 (1995-03-01), None
patent: WO 95/14023 (1995-05-01), None
patent: WO 2005/084673 (2005-09-01), None
patent: WO 2005/085257 (2005-09-01), None
patent: WO 2005/121327 (2005-12-01), None
patent: WO 2006/068905 (2006-06-01), None
patent: WO 2006/068932 (2006-06-01), None
Testa, Prodrugs Revisited: The “Ad Hoc” Approach as a Complement to Ligand Design, Medicinal Research Reviews, 16(3):233-241, (1996).
Salituro et al, Meridamycin: A Novel Nonimmunosuppressive FKBP12 Ligand FromStreptomyces hygroscopicus, Tetrahedron Letters, vol. 36, No. 7, pp. 997-1000, (1995).
Summers et al, 3-Normeridamycin: A Potent Non-Immunosuppressive Immunophilin Ligand is Neuroprotective in Dopaminergic Neurons, J. Antibiot. 59(3):184-189, (Mar. 2006).
H. Lin et al; Correlation Between Hippocampal Mossy Fiber Sprouting and Synaptic Reorganization and Mechanisms of Temporal Lobe Epilepsy; Zhonghua Yi Xue Za Zhi; vol. 87(5) pp. 341-344; 2007.
L. A. Shapiro et al; Integration of Newly Born Dentate Granule Cells Into Adult Brains; Hypotheses Based on Normal and Epileptic Rodents; Brain Res Brain Res Rev; vol. 48(1); pp. 43-56; 2005.
A. Knopp et al; Cellular and Network Properties of the Subiculum in the Pilocarpine Model of Termporal Lobe Epilepsy; j Comp Neurol; vol. 483(4); Pgsl; 475-488; 2005.
C. E. Bandtlow et al; Increased Expression of Nogo-A in Hippompl Neurons of Patients With Temporal Lobe Epilepsy; Eur J. Neurosci; vol. 20(1); pp. 195-206; 2004.
X. Bao et al; Brain Dev; Alpers Syndrome With Prominent WHIT4E Matter Changes vol. 30(4; 2008(4) 2008.
A. Simonati et al.; Features of Cell Death in Brain and Liver, The Target Tissues of Progressive Neuronal Degeneration of Childhood With Liver Disease (Alphers-Huttennlocher Disease); Acta Neuropathol; vol. 106(1); pp. 57-65; 2003.
S. Ulmer et al; Detectionof Acute Cytotoxic Changes in Progressive Neuronal Degenerationof Childhood With Liever Disease (Alpers-Huttenlocher Syndrome) Using Diffusion-Weighted MRI and MR Spectorscopy; J. Comput Assist Tomogr; vol. 26(4); pp. 641-656; 2002.
J. E. Kang et al; Regulationof the Proapoptotic Acitivty of Huntingtin Interacting Protein 1 by DYRK1 and Caspases-3 in Hippodampail Neuroprogenitor Cells; J. Neurosci Res; vol. 81(1); pp. 62-72; 2005.
G. Douaud et al; In Vivo Evidence for the Selective Subcortical Degeneration in Huntington'S Disease; Neuroimage; vol. 46(4); pp. 958-966; 2009.
P. R. Joshi et al; Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease; J. Neurosci; vol. 29(8); pp. 2414-2427; 2009.
J. Spampanato et al.; Progressive Synaptic Pathology of Motor Cortical Neurons in a BAC Transgenic Mouse Model of Huntington'S Disease; Neuroscience; vol. 157(3); pp. 606-620; 2008.
A. Thompson et al; Changes in Adult Neurogenesis in Neurodegenerative Diseases; Cause or Consequence?; Genes Brain Behav.; Suppl 1; pp. 28-42; 2008.
A.E. Metz et al; Morphological and Functional Reorganization of Rat Medial Prefrontal Cortex in Neuropathic Pain; Proc. Natl Acad Sci USA; vol. 106(7) pp. 2423-2428; 2009.
Y. S. Kim et al; Protective Effect of Gabapentin on N-Methyl-D-Aspartate-Induced Excitotoxicity in Rat Hippocampal CA1 Neurons; J. Pharmacol Sci; vol. 109(1); pp. 144-147; 2009.
P. V. Belichenko et al; Widespread Changes in Dendritic and Axonal Morphology in MECP2-Mutant Mouse Models of Rett Syndrome; Evidence for Disruption of Neuronal Networks; J. Comp Neurol; vol. 514(3) pp. 240-258; 2009.
M. Fischer et al; Enhanced Hupoxia Susceptibility in Hippocampal Slices Froma Mouse Model of Rett Syndrome; J. Neurophysio; vol. 101(2); pp. 1016-1032; 2009.
R. D. Smrt et al; MECP2 Deficiency Leads to Delayed Maturation and Altered Gene Expresion in Hippocampai Neurons; Neurobio Dis. ; vol. 27(1); pp. 77-89; 2007.
V. S. Dani et al; Reduced Cortical Activity Due to a Shift in the Balance Between Excitation and Inhibiton ina Mouse Model of Rett Syndrome; Proc Natl Acad Sci USA; vol. 102(35); pp. 12560-12565; 2005.
P. Filipcik et al; Corticall and Hippocampl Neurons From Truncated Tau Transgenic Rat Express Multiple Lmarkers of Neurodegeneration; Cell Mol Neurobiol; 2009.
J B Melo et al; Galantamine Protects Against Oxidative Stress Induced by Amyuloid-Beta Peptide in Cortical Neurons; Eur J. Neurosci; vol. 29(3); pp. 455-464; 2009.
B. Malik et al; Cell Cycle-Drive Neuronal Apoptosis Specficially Linked to Anmyloid Peptide ABeta1-42 Exposure is not Exacertated in a Mouse Model of Presenliin-1 Familial Alzheimer's Disease; J. Neurochem; vol. 106(2); pp. 912-916; 2008.
A Rametti et al; Lithium Down-Regulates Tau in Cultured Cortical Neurons; A Possible Mechanism of Neuroprotection; Neurosci Lett; vol. 434(1); pp. 93-98; 2008.
M N Vieira et al; Soluble Oligomers From a Non-Disease Related Protein Mimic ABeta-Induced Tau Hyperphosphorylation and Neurodegeneration; J. Neurochem; vol. 103(2); pp. 736-748; 2007.
M Hu et al; High Content Screen Microscopy Analysis of a Beta 1-42 Induced Neurite Outgrowth Reduction in Rat Primary Cortical Neurons; Neuroprotective Effects of Alpha 7 Neuronal Nicotinic Acetylcholine Receptor Ligands; Brain Res.; vol. 1151; pp. 227-235; 2007.
H Oakley et al; Intraneuronal Beta-Amyloid Aggregates, Neurodegeneration, D Neuron Loss in Transgenic Mice With Five Familal Alzheimer's Disease Mutations; Potential Factors in Amyloid Plaque Formatin; J. Neurosci; vol. 26(40); pp. 10129-10140; 2006.
C. Culmsee et al; Molecular Insights Into Mechanisms of the Cell Death Program: Role in the Progression of Neurodegenerative Disorders; Curr Alzheimer Res.; vol. 3(4); pp. 269-283; 2006.
G E Hoffman et al; Neuroprotection by Ovarian Hormones in Animal Models of Neurological Disease; Endocrine; vol. 29(2); pp. 217-231; 2006.
I. Merchanthaler et al; Neuroprotection by Estrogen in Animal Models of Global and Focal Ischemia; Ann N Y Acad Sci; vol. 1007; pp. 89-100; 2003.
W C Shuy et al; Secretoneurin Promotes Neuorportection and Neuronal Plasticity Via the JAK2/STAT3 Pathway in Murine Models of Stroke; J. Clin Invest; vol. 118(1); pp. 133-148; 2008.
C Wiessner et al; Anti-Nogo-A Antibody Infusion 24 Hours After Experimaental Stroke Improved Behavioral Outcome and Corticospinal Plasticity in Normotensive and Spontaneously Hypertensive Rats; J. Cereb Blood Flow Metab; vol. 23(2); pp. 154-165; 2003.
R. Dutta et al; Activation of the Cililary Neurotrophic Factor (CNTF) Signalling Pathway in Cortical Neurons of Multiple Sclerosis Patients; Brain; vol. 130(Pt 10) pp. 2566-2576; 2007.
P N Koutsoudaki et al; Demyelination of the Hippocampus is Prominent in the Cuprizone Model; Neurosci lett; vol. 451(1); pp. 83-88; 2009.
J J Geurts et al; Grey Matter Pathology in Multiple Sclerosis; Lancet Neurol; vol. 7(9); pp. 841-851; 2008.
D K Cullen et al; Collagen-Dependent Neurite Outgrowth and Response to Dynamic Deformation in Three-Dimensional Neuronal Cultures; Ann Biomed Eng; vol. 35(5); pp. 835-846; 2007.
P M Lenzlinger et al; Delayed Inhibition of Nogo-A Does Not Alter Injury0induced Axonal Sprouting but Enhances Recovery of Cognitive Function Following Experimental Traumatic Brain Injury in Rats; Neuroscience; vol. 134(3); pp. 1047-1056; 2005.
M J Jurynec et al; TIGR is Upregulated in the Chronci Glial Scar in Response to Cnetral Nervous System Injury and Inhibits Neurite Outgrowth; Mol Cell Neurosci; vol. 23(1); pp. 69-80; 2003.
JJ Ramirez et al; Basic Fibroblast Growth Factor Enchances Axonall Srpouting After Cortical Injury in Rats; Neuroreport; vol. 10(6); pp. 1201-1204; 1999.
H Peng et al; Epidermal Growth Factor Protects Neuronal C
Graziani Edmund Idris
Pong Kevin
Herman Michael J.
Kifle Bruck
Wyeth LLC
LandOfFree
Meridamycin analogues for the treatment of neurodegenerative... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Meridamycin analogues for the treatment of neurodegenerative..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Meridamycin analogues for the treatment of neurodegenerative... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4236530